Results 141 to 150 of about 10,632 (179)

The Effect of Different Meal Types on the Pharmacokinetics of Darunavir (TMC114)/Ritonavir in HIV-Negative Healthy Volunteers

Journal of Clinical Pharmacology, 2007
Richard M W Hoetelmans, Eric Lefebvre
exaly  

Enhanced oral bioavailability and brain uptake of Darunavir using lipid nanoemulsion formulation

Colloids and Surfaces B: Biointerfaces, 2019
Jagruti Desai, Hetal Thakkar
exaly  

Darunavir/ritonavir

Reactions Weekly, 2014
openaire   +2 more sources

Pharmacokinetics of darunavir in fixed‐dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers

Journal of Clinical Pharmacology, 2014
Thomas Kakuda
exaly  

Pharmacokinetic profile and safety of adjusted doses of darunavir/ritonavir with rifampicin in people living with HIV

Journal of Antimicrobial Chemotherapy, 2020
Helen Mcilleron, Lubbe Wiesner, Catherine Orrell   +2 more
exaly  

Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients

Pharmacological Research, 2012
Emilio Clementi, Cristina Gervasoni, Giuliano Rizzardini   +2 more
exaly  

Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV‐1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily

HIV Medicine, 2014
Thomas Kakuda
exaly  

Process for the preparation of darunavir and darunavir intermediates

2011
MIZHIRITSKII MICHAEL, MAROM EHUD
openaire   +4 more sources

Cobicistat/darunavir

Reactions Weekly, 2019
openaire   +2 more sources

Etravirine/darunavir

Reactions Weekly, 2022
openaire   +1 more source